Humacyte (HUMA) Short Interest
Nasdaq • HUMA • US44486Q1031
As of Oct 27, 2026, ORTEX estimated 11.4% of free float sold short, 4.4 days to cover, cost to borrow 2.36%. Sign up for live short interest data.
Nasdaq • HUMA • US44486Q1031
As of Oct 27, 2026, ORTEX estimated 11.4% of free float sold short, 4.4 days to cover, cost to borrow 2.36%. Sign up for live short interest data.
This page tracks how heavily Humacyte (Nasdaq:HUMA) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Humacyte (Nasdaq: HUMA) has a market capitalization of $166.68M. Last close $0.59 (as of 2026-11-12); 52-week range $0.34 to $1.53. ORTEX data as of 2026-10-27: short interest was 11.4% of free float, 4.4 days to cover and the average cost to borrow was 2.36%. Sign up for live short interest data.